GlaxoSmithKline plc Stock Price, News & Analysis (LON:GSK)

GBX 1,308 -10.00 (-0.76 %)
(As of 11/18/2017 01:40 AM ET)
Previous CloseGBX 1,308
Today's RangeGBX 1,317.83 - GBX 1,300
52-Week RangeGBX 1,311 - GBX 1,724.50
Volume6.44 million shs
Average Volume9.72 million shs
Market Capitalization£64.54 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About GlaxoSmithKline plc (LON:GSK)

GlaxoSmithKline plc logoGlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.


Industry, Sector and Symbol:
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Sector: Pharmaceuticals - NEC
  • Symbol: LON:GSK
  • CUSIP: N/A
  • Web: www.gsk.com
Profitability:
  • Trailing EPS: GBX 0.48
  • Net Margins: 17.79%
  • Return on Equity: 461.88%
  • Return on Assets: 9.56%
Misc:
  • Outstanding Shares: 4,920,000,000
 

Frequently Asked Questions for GlaxoSmithKline plc (LON:GSK)

What is GlaxoSmithKline plc's stock symbol?

GlaxoSmithKline plc trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline plc pay dividends? What is the dividend yield for GlaxoSmithKline plc?

GlaxoSmithKline plc announced a dividend on Wednesday, October 25th. Shareholders of record on Thursday, November 9th will be paid a dividend of GBX 19 per share on Thursday, January 11th. This represents a yield of 1.41%. The ex-dividend date is Thursday, November 9th. The official announcement can be accessed at this link. View GlaxoSmithKline plc's Dividend History.

How were GlaxoSmithKline plc's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) posted its earnings results on Wednesday, October, 25th. The company reported $32.50 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $31.80 by $0.70. The company earned $7.84 billion during the quarter. GlaxoSmithKline plc had a net margin of 17.79% and a return on equity of 461.88%. View GlaxoSmithKline plc's Earnings History.

Where is GlaxoSmithKline plc's stock going? Where will GlaxoSmithKline plc's stock price be in 2017?

19 analysts have issued 1-year price objectives for GlaxoSmithKline plc's shares. Their predictions range from GBX 1,300 to GBX 1,775. On average, they expect GlaxoSmithKline plc's share price to reach GBX 1,548.33 in the next year. View Analyst Ratings for GlaxoSmithKline plc.

Who are some of GlaxoSmithKline plc's key competitors?

Who are GlaxoSmithKline plc's key executives?

GlaxoSmithKline plc's management team includes the folowing people:

  • Emma Walmsley, Chief Executive Officer, Executive Director (Age 47)
  • Simon Dingemans, Chief Financial Officer, Executive Director (Age 53)
  • Patrick Vallance, President - R&D, Executive Director (Age 56)
  • Roger Connor, President - Global Manufacturing & Supply
  • Luc Debruyne, President - Global Vaccines
  • Abbas Hussain, President - Global Pharmaceuticals
  • Shah Abbas Hussain, President - Global Pharmaceuticals
  • Brian McNamara, Chief Executive Officer - GSK Consumer Healthcare (Age 50)
  • Luke Miels, President - Global Pharmaceuticals
  • Daniel E. Troy, Senior Vice President, General Counsel

How do I buy GlaxoSmithKline plc stock?

Shares of GlaxoSmithKline plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline plc's stock price today?

One share of GlaxoSmithKline plc stock can currently be purchased for approximately GBX 1,308.

How big of a company is GlaxoSmithKline plc?

GlaxoSmithKline plc has a market capitalization of £64.54 billion.

How can I contact GlaxoSmithKline plc?

GlaxoSmithKline plc's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline plc (LON GSK)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  506 (Vote Outperform)
Underperform Votes:  1,197 (Vote Underperform)
Total Votes:  1,703
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for GlaxoSmithKline plc (LON:GSK)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 11 Hold Ratings, 5 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.11)
Consensus Price Target: GBX 1,548.33

Consensus Price Target History for GlaxoSmithKline plc (LON:GSK)

Price Target History for GlaxoSmithKline plc (LON:GSK)

Analysts' Ratings History for GlaxoSmithKline plc (LON:GSK)

Show:
DateFirmActionRatingPrice TargetDetails
11/16/2017Jefferies Group LLCLower Price TargetBuyGBX 1,540 -> GBX 1,450View Rating Details
11/6/2017InvestecDowngradeHoldGBX 1,800 -> GBX 1,390View Rating Details
11/9/2017Societe GeneraleReiterated RatingSellView Rating Details
11/9/2017Citigroup Inc.Reiterated RatingNeutralView Rating Details
11/9/2017Liberum CapitalReiterated RatingBuyGBX 1,760View Rating Details
11/8/2017Beaufort SecuritiesLower Price TargetBuyGBX 1,800 -> GBX 1,450View Rating Details
11/6/2017Morgan StanleySet Price TargetSellGBX 1,450View Rating Details
11/2/2017Berenberg BankLower Price TargetBuyGBX 1,835 -> GBX 1,760View Rating Details
11/1/2017Kepler Capital MarketsLower Price TargetReduceGBX 1,520 -> GBX 1,340View Rating Details
10/29/2017J P Morgan Chase & CoLower Price TargetNeutralGBX 1,570 -> GBX 1,330View Rating Details
10/27/2017Barclays PLCReiterated RatingEqual weightGBX 1,450View Rating Details
10/27/2017The Goldman Sachs Group, Inc.Set Price TargetBuyGBX 1,775View Rating Details
10/27/2017Deutsche Bank AGSet Price TargetNeutralGBX 1,610View Rating Details
10/26/2017Bank of America CorporationSet Price TargetNeutralGBX 1,550View Rating Details
10/26/2017S&P GlobalSet Price TargetNeutralGBX 1,500View Rating Details
10/23/2017Shore CapitalReiterated RatingHoldView Rating Details
9/19/2017Bryan, Garnier & CoReiterated RatingNeutralGBX 1,710View Rating Details
9/6/2017BNP ParibasSet Price TargetNeutralGBX 1,620View Rating Details
9/6/2017Credit Suisse GroupLower Price TargetNeutralGBX 1,775 -> GBX 1,725View Rating Details
10/27/2016NatixisReiterated RatingNeutralGBX 1,750View Rating Details
10/19/2016Sanford C. BernsteinSet Price TargetNeutralGBX 1,834View Rating Details
8/4/2016Independent Research GmbHSet Price TargetNeutralGBX 1,800View Rating Details
7/27/2016S&P Global Inc.Set Price TargetNeutralGBX 1,650View Rating Details
7/7/2016Canaccord GenuityReiterated RatingHoldGBX 1,785View Rating Details
3/10/2016AlphaValueReiterated RatingAddGBX 1,536View Rating Details
2/12/2016Baader BankReiterated RatingHoldGBX 1,530View Rating Details
1/28/2016Leerink SwannReiterated RatingMarket PerformGBX 1,565View Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for GlaxoSmithKline plc (LON:GSK)

Earnings by Quarter for GlaxoSmithKline plc (LON:GSK)

Earnings History by Quarter for GlaxoSmithKline plc (LON GSK)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017Q3 2017GBX 31.80GBX 32.50GBX 784.30 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for GlaxoSmithKline plc (LON:GSK)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for GlaxoSmithKline plc (LON GSK)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/25/2017GBX 191.41%11/9/201711/9/20171/11/2018
7/26/2017GBX 191.23%8/10/20178/10/201710/12/2017
4/26/2017GBX 191.21%5/11/20175/11/20177/13/2017
2/8/2017GBX 231.47%2/23/20172/23/20174/13/2017
10/26/2016GBX 191.17%11/3/201611/3/20161/12/2017
7/27/2016GBX 191.12%8/11/20168/11/201610/13/2016
4/27/2016GBX 191.28%5/12/20165/12/20167/14/2016
10/28/2015GBX 191.34%11/12/201511/12/20151/14/2016
10/28/2015GBX 201.34%2/18/20162/18/20164/14/2016
7/29/2015GBX 191.38%8/13/20158/13/201510/1/2015
5/6/2015GBX 191.25%5/14/20155/14/20157/9/2015
2/4/2015GBX 231.56%2/19/20152/19/20154/9/2015
10/22/2014GBX 191.37%11/6/201411/6/20141/8/2015
7/23/2014GBX 191.28%8/6/20148/6/201410/2/2014
4/30/2014GBX 191.17%5/14/20145/14/20147/10/2014
2/5/2014GBX 231.36%2/19/20142/19/20144/10/2014
10/23/2013GBX 191.15%11/13/201311/13/20131/9/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for GlaxoSmithKline plc (LON GSK)

Insider Trades by Quarter for GlaxoSmithKline plc (LON:GSK)

Insider Trades by Quarter for GlaxoSmithKline plc (LON GSK)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2017Patrick VallanceInsiderBuy10GBX 1,364£136.40
10/25/2017Urs RohnerInsiderBuy473GBX 1,518£7,180.14
10/12/2017Simon DingemansInsiderBuy1,076GBX 1,527£16,430.52
10/10/2017Victoria WhyteInsiderBuy9GBX 1,518£136.62
9/11/2017Dominic RedfernInsiderBuy8GBX 1,501£120.08
8/9/2017Dominic RedfernInsiderBuy8GBX 1,519£121.52
7/26/2017Manvinder Singh BangaInsiderBuy2,267GBX 1,599£36,249.33
7/14/2017Patrick VallanceInsiderBuy861GBX 1,618£13,930.98
7/11/2017Victoria WhyteInsiderBuy8GBX 1,604£128.32
6/20/2017Victoria WhyteInsiderSell4,820GBX 1,693£81,602.60
6/9/2017Simon DingemansInsiderBuy7GBX 1,701£119.07
5/10/2017Patrick VallanceInsiderBuy7GBX 1,615£113.05
4/26/2017Vivienne CoxInsiderBuy335GBX 1,583£5,303.05
4/18/2017Emma WalmsleyInsiderBuy83GBX 1,647£1,367.01
4/13/2017Dominic RedfernInsiderBuy230GBX 1,639£3,769.70
3/9/2017Sir Andrew P WittyInsiderBuy7GBX 1,673£117.11
3/7/2017Moncef SlaouiInsiderBuy56GBX 2,072£1,160.32
2/22/2017Simon DingemansInsiderSell3,589GBX 1,640£58,859.60
2/20/2017Sir Andrew P WittyInsiderSell10,633GBX 1,634£173,743.22
2/16/2017Patrick VallanceInsiderSell32,996GBX 1,624£535,855.04
2/9/2017Victoria WhyteInsiderSell4,820GBX 1,576£75,963.20
2/8/2017Vivienne CoxInsiderBuy342GBX 1,555£5,318.10
1/11/2017Simon DingemansInsiderBuy8GBX 1,596£127.68
1/9/2017Moncef SlaouiInsiderBuy58GBX 1,972£1,143.76
12/9/2016Sir Andrew P WittyInsiderBuy8GBX 1,478£118.24
11/9/2016Victoria WhyteInsiderBuy8GBX 1,593£127.44
11/3/2016Moncef SlaouiInsiderBuy6GBX 1,937£116.22
10/27/2016Sir Andrew P WittyInsiderSell10,000GBX 1,636£163,600
10/26/2016Manvinder Singh BangaInsiderBuy1,750GBX 1,643£28,752.50
10/11/2016Simon DingemansInsiderBuy7GBX 1,728£120.96
10/7/2016Moncef SlaouiInsiderBuy4GBX 2,148GBX 8,592
9/22/2016Moncef SlaouiInsiderBuy2GBX 2,179GBX 4,358
9/9/2016Witty,Sir Andrew PInsiderBuy8GBX 1,616£129.28
8/12/2016Slaoui,MoncefInsiderBuy28GBX 2,208£618.24
8/9/2016Dingemans,SimonInsiderBuy8GBX 1,680£134.40
7/27/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,693£169,300
7/11/2016Witty,Sir Andrew PInsiderBuy7GBX 1,671£116.97
7/8/2016Slaoui,MoncefInsiderBuy4GBX 2,169GBX 8,676
7/1/2016Cartwright,StaceyInsiderBuy461GBX 1,559£7,186.99
6/9/2016Dingemans,SimonInsiderBuy9GBX 1,441£129.69
5/20/2016Slaoui,MoncefInsiderBuy14GBX 2,100£294
5/12/2016Slaoui,MoncefInsiderBuy24GBX 2,103£504.72
5/11/2016Witty,Sir Andrew PInsiderBuy8GBX 1,476£118.08
4/28/2016Witty,Sir Andrew PInsiderSell10,000GBX 1,475£147,500
4/14/2016Slaoui,MoncefInsiderBuy495GBX 2,156£10,672.20
3/31/2016Anderson,Sir RoyInsiderBuy511GBX 1,405£7,179.55
3/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,404£126.36
2/15/2016Dingemans,SimonInsiderSell39,987GBX 1,406£562,217.22
2/9/2016Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21
1/28/2016Dingemans,SimonInsiderBuy684GBX 1,381£9,446.04
1/14/2016Witty,Sir Andrew PInsiderBuy43GBX 1,369£588.67
1/12/2016Dingemans,SimonInsiderBuy9GBX 1,359£122.31
12/9/2015Dingemans,SimonInsiderBuy9GBX 1,325£119.25
11/10/2015Dingemans,SimonInsiderBuy9GBX 1,366£122.94
10/12/2015Dingemans,SimonInsiderBuy10GBX 1,307£130.70
10/1/2015Rohner,UrsInsiderBuy525GBX 1,251£6,567.75
9/10/2015Witty,Sir Andrew PInsiderBuy10GBX 1,318£131.80
8/12/2015Dingemans,SimonInsiderBuy8GBX 1,443£115.44
7/10/2015Witty,Sir Andrew PInsiderBuy9GBX 1,369£123.21
7/1/2015Wijers,HansInsiderBuy534GBX 13.45GBX 7,182.30
3/31/2015Sir Christopher GentInsiderBuy3,991GBX 1,566£62,499.06
3/9/2015Moncef SlaouiInsiderSell22,274GBX 1,544£343,910.56
2/18/2015Moncef SlaouiInsiderSell1,580GBX 1,553£24,537.40
2/13/2015Simon DingemansInsiderSell12,605GBX 1,543.12£194,510.28
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for GlaxoSmithKline plc (LON GSK)

Source:
DateHeadline
Jefferies Group LLC Cuts GlaxoSmithKline plc (GSK) Price Target to GBX 1,450Jefferies Group LLC Cuts GlaxoSmithKline plc (GSK) Price Target to GBX 1,450
www.americanbankingnews.com - November 19 at 12:16 AM
Theravance Shares Rise on Approval of Glaxos COPD TherapyTheravance Shares Rise on Approval of Glaxo's COPD Therapy
finance.yahoo.com - November 17 at 5:53 PM
Glaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EUGlaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EU
finance.yahoo.com - November 17 at 5:53 PM
Theravance Shares Rise on Approval of Glaxo's COPD TherapyTheravance Shares Rise on Approval of Glaxo's COPD Therapy
finance.yahoo.com - November 17 at 5:53 PM
VBI: Multiple Platforms Yield a Portfolio of VaccinesVBI: Multiple Platforms Yield a Portfolio of Vaccines
finance.yahoo.com - November 13 at 7:21 PM
Interview: Bill Gates makes $100 million personal investment to fight AlzheimersInterview: Bill Gates makes $100 million personal investment to fight Alzheimer's
finance.yahoo.com - November 13 at 9:25 AM
Deleterious Earnings Momentum Drop GlaxoSmithKline (GSK) to Sell - Investorplace.comDeleterious Earnings Momentum Drop GlaxoSmithKline (GSK) to Sell - Investorplace.com
investorplace.com - November 11 at 8:48 AM
GlaxoSmithKline Plc : GSK-GB: Dividend Analysis : November 10th, 2017 (record date) : By the numbers : November 11, 2017GlaxoSmithKline Plc : GSK-GB: Dividend Analysis : November 10th, 2017 (record date) : By the numbers : November 11, 2017
finance.yahoo.com - November 11 at 8:48 AM
It's Not Too Late to Buy Dynavax Stock After Its Hepatitis B Vaccine ApprovalIt's Not Too Late to Buy Dynavax Stock After Its Hepatitis B Vaccine Approval
finance.yahoo.com - November 11 at 8:48 AM
GlaxoSmithKline plc (GSK) Insider Patrick Vallance Purchases 10 SharesGlaxoSmithKline plc (GSK) Insider Patrick Vallance Purchases 10 Shares
www.americanbankingnews.com - November 10 at 9:22 AM
Hikma in dispute with FDA over generic Advair, cuts generics sales forecast againHikma in dispute with FDA over generic Advair, cuts generics sales forecast again
finance.yahoo.com - November 9 at 6:19 AM
Thousands of drugs face Brexit risk, makers to duplicate testingThousands of drugs face Brexit risk, makers to duplicate testing
finance.yahoo.com - November 9 at 6:19 AM
Beaufort Securities Lowers GlaxoSmithKline plc (GSK) Price Target to GBX 1,450Beaufort Securities Lowers GlaxoSmithKline plc (GSK) Price Target to GBX 1,450
www.americanbankingnews.com - November 8 at 9:50 AM
GlaxoSmithKline plc (GSK) Downgraded by InvestecGlaxoSmithKline plc (GSK) Downgraded by Investec
www.americanbankingnews.com - November 6 at 3:40 PM
GlaxoSmithKline plc (GSK) to Issue Dividend of GBX 19GlaxoSmithKline plc (GSK) to Issue Dividend of GBX 19
www.americanbankingnews.com - November 4 at 10:35 AM
GSKs (GSK) BCMA Antibody-drug Conjugate Receives Breakthrough Therapy Designation for R/R Multiple MyelomaGSK's (GSK) BCMA Antibody-drug Conjugate Receives Breakthrough Therapy Designation for R/R Multiple Myeloma
www.streetinsider.com - November 3 at 9:13 PM
BRIEF-GSK and Innoviva announce positive data from COPD studyBRIEF-GSK and Innoviva announce positive data from COPD study
www.businessinsider.com - November 3 at 9:13 PM
GSK gets boost for early cancer hopes with breakthrough statusGSK gets boost for early cancer hopes with breakthrough status
finance.yahoo.com - November 3 at 5:06 AM
GlaxoSmithKline Wins FDA Approval to Develop Breakthrough Blood Cancer DrugGlaxoSmithKline Wins FDA Approval to Develop 'Breakthrough' Blood Cancer Drug
finance.yahoo.com - November 3 at 5:06 AM
GSK and Gilead go head to head as HIV drugs enter new phaseGSK and Gilead go head to head as HIV drugs enter new phase
finance.yahoo.com - November 3 at 5:06 AM
Former GSK boss to lead new UK accelerated drug access schemeFormer GSK boss to lead new UK accelerated drug access scheme
finance.yahoo.com - November 3 at 5:05 AM
GSKs R&D head to leave for top UK government job - sourceGSK's R&D head to leave for top UK government job - source
finance.yahoo.com - November 3 at 5:05 AM
GlaxoSmithKline plc (GSK) Given a GBX 1,075 Price Target by Societe Generale AnalystsGlaxoSmithKline plc (GSK) Given a GBX 1,075 Price Target by Societe Generale Analysts
www.americanbankingnews.com - October 27 at 10:34 AM
Glaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down - NasdaqGlaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down - Nasdaq
www.nasdaq.com - October 27 at 3:11 AM
Glaxo Will Consider Bid for Pfizers Consumer-Health Unit, Chief Says - Wall Street JournalGlaxo Will Consider Bid for Pfizer's Consumer-Health Unit, Chief Says - Wall Street Journal
www.wsj.com - October 27 at 3:11 AM
Bank of America Corporation Analysts Give GlaxoSmithKline plc (GSK) a GBX 1,550 Price TargetBank of America Corporation Analysts Give GlaxoSmithKline plc (GSK) a GBX 1,550 Price Target
www.americanbankingnews.com - October 26 at 12:20 PM
GlaxoSmithKline Q3 Profit Rises; Affirms FY OutlookGlaxoSmithKline Q3 Profit Rises; Affirms FY Outlook
www.rttnews.com - October 26 at 9:13 AM
U.S. Tax Overhaul Would Be a Boon For GSK, CFO SaysU.S. Tax Overhaul Would Be a Boon For GSK, CFO Says
blogs.wsj.com - October 26 at 9:13 AM
US Committee backs Glaxos shingles vaccine - MarketWatchUS Committee backs Glaxo's shingles vaccine - MarketWatch
www.marketwatch.com - October 26 at 9:13 AM
GlaxoSmithKline stock plummets 6% after concerns about dividend risk - MarketWatchGlaxoSmithKline stock plummets 6% after concerns about dividend risk - MarketWatch
www.marketwatch.com - October 26 at 9:13 AM
GlaxoSmithKline Plc (GSK) Q3 2017 Results - Earnings Call Transcript - Seeking AlphaGlaxoSmithKline Plc (GSK) Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - October 26 at 9:13 AM
GlaxoSmithKlines new boss struggles to sell cure for drugmakerGlaxoSmithKline's new boss struggles to sell cure for drugmaker
finance.yahoo.com - October 26 at 9:13 AM
GlaxoSmithKline plc (GSK) Given a GBX 1,500 Price Target by S&P Global AnalystsGlaxoSmithKline plc (GSK) Given a GBX 1,500 Price Target by S&P Global Analysts
www.americanbankingnews.com - October 26 at 6:24 AM
Urs Rohner Acquires 473 Shares of GlaxoSmithKline plc (GSK) StockUrs Rohner Acquires 473 Shares of GlaxoSmithKline plc (GSK) Stock
www.americanbankingnews.com - October 25 at 2:39 PM
GlaxoSmithKline plc (GSK) Issues Quarterly  Earnings Results, Beats Expectations By $0.70 EPSGlaxoSmithKline plc (GSK) Issues Quarterly Earnings Results, Beats Expectations By $0.70 EPS
www.americanbankingnews.com - October 25 at 10:32 AM
Should You Buy GlaxoSmithKline (GSK) Ahead of Earnings? - NasdaqShould You Buy GlaxoSmithKline (GSK) Ahead of Earnings? - Nasdaq
www.nasdaq.com - October 25 at 3:08 AM
GlaxoSmithKline plc (GSK) Given a GBX 1,600 Price Target at UBS AGGlaxoSmithKline plc (GSK) Given a GBX 1,600 Price Target at UBS AG
www.americanbankingnews.com - October 23 at 11:54 AM
GlaxoSmithKline plc (GSK) Earns Neutral Rating from J P Morgan Chase & CoGlaxoSmithKline plc (GSK) Earns Neutral Rating from J P Morgan Chase & Co
www.americanbankingnews.com - October 23 at 6:44 AM
Britain backs GSKs gene therapy for bubble boy syndromeBritain backs GSK's gene therapy for 'bubble boy' syndrome
finance.yahoo.com - October 22 at 10:59 PM
Improving Analytics Lift Ranking of GlaxoSmithKline (GSK) to Hold - Investorplace.comImproving Analytics Lift Ranking of GlaxoSmithKline (GSK) to Hold - Investorplace.com
investorplace.com - October 21 at 1:43 AM
GlaxoSmithKline plc (GSK) Given a GBX 1,600 Price Target by Morgan Stanley AnalystsGlaxoSmithKline plc (GSK) Given a GBX 1,600 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - October 18 at 11:38 AM
Glaxos Shingles Vaccine Shingrix Gets Approval in CanadaGlaxo's Shingles Vaccine Shingrix Gets Approval in Canada
finance.yahoo.com - October 17 at 1:59 AM
GlaxoSmithKline plc (GSK) Insider Simon Dingemans Purchases 1,076 SharesGlaxoSmithKline plc (GSK) Insider Simon Dingemans Purchases 1,076 Shares
www.americanbankingnews.com - October 16 at 4:32 PM
GSK January 2020 Options Begin TradingGSK January 2020 Options Begin Trading
www.nasdaq.com - October 16 at 3:56 PM
Deutsche Bank AG Analysts Give GlaxoSmithKline plc (GSK) a GBX 1,610 Price TargetDeutsche Bank AG Analysts Give GlaxoSmithKline plc (GSK) a GBX 1,610 Price Target
www.americanbankingnews.com - October 15 at 4:36 PM
GlaxoSmithKlines shingles vaccine gets approval in CanadaGlaxoSmithKline's shingles vaccine gets approval in Canada
finance.yahoo.com - October 13 at 7:03 PM
GlaxoSmithKline plc (GSK) Given Consensus Recommendation of "Hold" by AnalystsGlaxoSmithKline plc (GSK) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - October 12 at 4:44 AM
Insider Buying: GlaxoSmithKline plc (GSK) Insider Purchases 9 Shares of StockInsider Buying: GlaxoSmithKline plc (GSK) Insider Purchases 9 Shares of Stock
www.americanbankingnews.com - October 11 at 10:20 AM
GlaxoSmithKline plc (GSK) Given a GBX 1,550 Price Target by UBS AG AnalystsGlaxoSmithKline plc (GSK) Given a GBX 1,550 Price Target by UBS AG Analysts
www.americanbankingnews.com - October 10 at 6:20 AM
GlaxoSmithKline (GSK) Keeps Sell Recommendation | InvestorPlace - Investorplace.comGlaxoSmithKline (GSK) Keeps Sell Recommendation | InvestorPlace - Investorplace.com
www.investorplace.com - October 7 at 12:45 AM

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

GlaxoSmithKline plc (LON GSK) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.